Permanent, bilateral common carotid artery occlusion in the rat: a model for chronic cerebral hypoperfusion-related neurodegenerative diseases

E Farkas, PGM Luiten, F Bari - Brain research reviews, 2007 - Elsevier
Chronic cerebral hypoperfusion has been associated with cognitive decline in aging and
Alzheimer's disease. Moreover, the pattern of cerebral blood flow in mild cognitive …

The enigma of vascular cognitive disorder and vascular dementia

KA Jellinger - Acta neuropathologica, 2007 - Springer
The prevalence, morphology and pathogenesis of vascular dementia (VaD), recently termed
vascular cognitive impairment, are a matter of discussion, and currently used clinical …

New treatment approaches to modify the course of cerebral small vessel diseases

EE Smith, HS Markus - Stroke, 2020 - Am Heart Assoc
Smith and Markus Cerebral Small Vessel Disease Trials 39 dysmetabolism, and glucose
dysregulation that are the primary targets for current ischemic stroke prevention. As an …

Cerebral small vessel disease (CSVD)–lessons from the animal models

M Mustapha, CMNCM Nassir, N Aminuddin… - Frontiers in …, 2019 - frontiersin.org
Cerebral small vessel disease (CSVD) refers to a spectrum of clinical and imaging findings
resulting from pathological processes of various etiologies affecting cerebral arterioles …

Cilostazol suppresses β‐amyloid production by activating a disintegrin and metalloproteinase 10 via the upregulation of SIRT1‐coupled retinoic acid receptor‐β

HR Lee, HK Shin, SY Park, HY Kim… - Journal of …, 2014 - Wiley Online Library
The accumulation of plaques of β‐amyloid (Aβ) peptides, a hallmark of Alzheimer's disease,
results from the sequential cleavage of amyloid precursor protein (APP) by activation of β …

Protective effect of the phosphodiesterase III inhibitor cilostazol on amyloid β-induced cognitive deficits associated with decreased amyloid β accumulation

SH Park, JH Kim, SS Bae, KW Hong, DS Lee… - Biochemical and …, 2011 - Elsevier
Abstract Alzheimer's disease (AD), which is characterized by progressive cognitive
impairment, is the most common neurodegenerative disease. Here, we investigated the …

Development of therapeutics that induce mitochondrial biogenesis for the treatment of acute and chronic degenerative diseases

RB Cameron, CC Beeson… - Journal of medicinal …, 2016 - ACS Publications
Mitochondria have various roles in cellular metabolism and homeostasis. Because
mitochondrial dysfunction is associated with many acute and chronic degenerative …

Cilostazol prevents amyloid β peptide25‐35‐induced memory impairment and oxidative stress in mice

M Hiramatsu, O Takiguchi… - British journal of …, 2010 - Wiley Online Library
BACKGROUND AND PURPOSE Cilostazol may be effective in dementia associated with a
cerebral ischaemia. In this study, we examined whether it exerts beneficial effects on …

Introduction for focused updates in cerebrovascular disease

LB Goldstein - Stroke, 2020 - Am Heart Assoc
5. Dwyer-Lindgren L, Bertozzi-Villa A, Stubbs RW, Morozoff C, Mackenbach JP, van Lenthe
FJ, et al. Inequalities in life expectancy among us counties, 1980 to 2014: temporal trends …

Cilostazol disrupts TLR-4, Akt/GSK-3β/CREB, and IL-6/JAK-2/STAT-3/SOCS-3 crosstalk in a rat model of Huntington's disease

H El-Abhar, MA Abd El Fattah, W Wadie… - Plos one, 2018 - journals.plos.org
Countless neurodegenerative diseases are associated with perverse multiple targets of
cyclic nucleotide signalling, hastening neuronal death. Cilostazol, a phosphodiesterase-III …